Affinity Asset Advisors »

Forte Biosciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $28M 1.0M 27.27

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Forte Biosciences

Federated Investors
Fred Alger Management
Henderson Group
OrbiMed Advisors
Affinity Asset Advisors
Tybourne Capital Management
Vanguard Group
Cable Car Capital
Point72 Asset Management
Adage Capital Partners GP
Woodline Partners
Ikarian Capital
FMR
AWM Investment Company
Sphera Funds Management

View all funds holding Forte Biosciences